<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
pmid: 18855526
Amodiaquine is a central drug in the new global strategy of combination therapies for the control of malaria. Amodiaquine is mainly metabolized hepatically towards its major active metabolite desethylamodiaquine, by the polymorphic P450 isoform CYP2C8. Amodiaquine is associated with rare but serious side effects, as well as with relatively frequent mild ones. These are expected to be at least partially related to CYP2C8 alleles. Pharmacogenetic knowledge of amodiaquine exposed populations is important for pharmacovigilance issues and in being a first step for future realistic applications from a personal medicine perspective.
Polymorphism, Genetic, Endemic Diseases, Plasmodium falciparum, Amodiaquine, Models, Biological, Antimalarials, Cytochrome P-450 Enzyme System, Pharmacogenetics, Animals, Humans, Malaria, Falciparum, Alleles, Forecasting, Half-Life
Polymorphism, Genetic, Endemic Diseases, Plasmodium falciparum, Amodiaquine, Models, Biological, Antimalarials, Cytochrome P-450 Enzyme System, Pharmacogenetics, Animals, Humans, Malaria, Falciparum, Alleles, Forecasting, Half-Life
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 30 | |
popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |